Dawn C. Bir
2021
In 2021, Dawn C. Bir earned a total compensation of $1.8M as Chief Commercial Officer and Executive Vice President at REATA PHARMACEUTICALS, a 53% decrease compared to previous year.
Compensation breakdown
| Bonus | $142,425 |
|---|---|
| Option Awards | $1,253,916 |
| Salary | $422,000 |
| Other | $5,000 |
| Total | $1,823,341 |
Bir received $1.3M in option awards, accounting for 69% of the total pay in 2021.
Bir also received $142.4K in bonus, $422K in salary and $5K in other compensation.
Rankings
In 2021, Dawn C. Bir's compensation ranked 6,399th out of 12,415 executives tracked by ExecPay. In other words, Bir earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,399 out of 12,415 | 49th |
Division Manufacturing | 2,733 out of 5,505 | 50th |
Major group Chemicals And Allied Products | 1,206 out of 2,375 | 49th |
Industry group Drugs | 1,074 out of 2,096 | 49th |
Industry Pharmaceutical Preparations | 776 out of 1,546 | 50th |
Pay ratio
| Dawn C. Bir's Pay | $1,823,341 |
|---|---|
| Median Employee's Pay | $244,581 |
| Pay Ratio | 7to 1 |
In 2021, the annual total compensation of Dawn C. Bir was $1,823,341.
The annual total compensation of the median employee at REATA PHARMACEUTICALS was $244,581.
The ratio of Dawn C. Bir's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 29, 2022.
Bir's colleagues
We found four more compensation records of executives who worked with Dawn C. Bir at REATA PHARMACEUTICALS in 2021.